Deletion of the antiphospholipid syndrome autoantigen β2- glycoprotein i potentiates the lupus autoimmune phenotype in a toll-like receptor 7-mediated murine model

Arthritis and Rheumatology

Volumn 66, Issue 8, 2014, Pages 2270-2280

  Giannakopoulos, Bill ^a   Mirarabshahi, Peyman ^a   Qi, Miao ^a   Weatherall, Chris ^a   Qi, Jian Cheng ^a   Tanaka, Kumiko ^a   Millar, Ewan ^a,b,c   Vonthethoff, Leon ^a   Gatto, Dominique ^a   Spielman, Derek ^d   Krilis, Steven A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; B CELL ACTIVATING FACTOR; BETA2 GLYCOPROTEIN 1; COMPLEMENTARY DNA; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BACKCROSSING; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE TRANSLOCATION; GENETIC MARKER; GLOMERULONEPHRITIS; LYMPHADENOPATHY; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; MURINE MODEL; NEW ZEALAND WHITE MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SEX DIFFERENCE; SPLEEN CELL; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS; WILD TYPE;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIGENS; BETA 2-GLYCOPROTEIN I; DISEASE MODELS, ANIMAL; GENE DELETION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PHENOTYPE; TOLL-LIKE RECEPTOR 7;

EID: 84904994276     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38646     Document Type: Article

References (39)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Giannakopoulos B, Krilis SA,. The pathogenesis of the antiphospholipid syndrome. N Engl J Med 2013; 368: 1033-44.
3. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA,. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990; 87: 4120-4.
4. Miyakis S, Giannakopoulos B, Krilis SA,. Beta 2 glycoprotein I: function in health and disease. Thromb Res 2004; 114: 335-46.
5. Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JW, Tanaka K, et al. Beta 2 glycoprotein I is a substrate of thiol oxidoreductases. Blood 2010; 116: 1995-7.
6. 2-glycoprotein I. Arthritis Rheum 2011; 63: 2774-82.
7. Ioannou Y, Zhang JY, Passam FH, Rahgozar S, Qi JC, Giannakopoulos B, et al. Naturally occurring free thiols within β2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury. Blood 2010; 116: 1961-70.
8. 2-glycoprotein I on apoptotic cells. Arthritis Rheum 2009; 60: 860-9.
9. Balasubramanian K, Maiti SN, Schroit AJ,. Recruitment of β-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis. Apoptosis 2005; 10: 439-46.
10. Maiti SN, Balasubramanian K, Ramoth JA, Schroit AJ,. Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells: binding to lipoprotein receptor-related protein receptor family members. J Biol Chem 2008; 283: 3761-6.
11. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-27.
12. Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA,. Prevalence of antibodies to β2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. J Rheumatol 2000; 27: 2833-7.
13. Hashimoto Y, Kawamura M, Ichikawa K, Suzuki T, Sumida T, Yoshida S, et al. Anticardiolipin antibodies in NZW x BXSB F1 mice: a model of antiphospholipid syndrome. J Immunol 1992; 149: 1063-8.
14. Monestier M, Kandiah DA, Kouts S, Novick KE, Ong GL, Radic MZ, et al. Monoclonal antibodies from NZW x BXSB F1 mice to β2 glycoprotein I and cardiolipin: species specificity and charge-dependent binding. J Immunol 1996; 156: 2631-41.
15. Reddel SW, Wang YX, Sheng YH, Krilis SA,. Epitope studies with anti-β2-glycoprotein I antibodies from autoantibody and immunized sources. J Autoimmun 2000; 15: 91-6.
16. Ida A, Hirose S, Hamano Y, Kodera S, Jiang Y, Abe M, et al. Multigenic control of lupus-associated antiphospholipid syndrome in a model of (NZW x BXSB) F1 mice. Eur J Immunol 1998; 28: 2694-703.
17. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S,. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006; 312: 1669-72.
18. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J, et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proce Nat Acad Sci U S A. 2006; 103: 9970-5.
19. Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005; 202: 1171-7.
20. Vollmer J, Tluk S, Schmitz C, Hamm S, Jurk M, Forsbach A, et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005; 202: 1575-85.
21. Sheng Y, Reddel SW, Herzog H, Wang YX, Brighton T, France MP, et al. Impaired thrombin generation in β2-glycoprotein I null mice. J Biol Chem 2001; 276: 13817-21.
22. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007; 27: 801-10.
23. Murphy ED, Roths JB,. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 1979; 22: 1188-94.
24. McPhee CG, Sproule TJ, Shin DM, Bubier JA, Schott WH, Steinbuck MP, et al. MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis. J Immunol 2011; 187: 4695-704.
25. Kubo C, Gajar A, Johnson BC, Good RA,. The effects of dietary restriction on immune function and development of autoimmune disease in BXSB mice. Proc Natl Acad Sci U S A 1992; 89: 3145-9.
26. Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity. Blood 2011; 118: 1305-15.
27. Hao Y, O'Neill P, Naradikian MS, Scholz JL, Cancro MP,. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 2011; 118: 1294-304.
28. Mackay F, Schneider P,. Cracking the BAFF code. Nat Rev Immunol 2009; 9: 491-502.
29. Ding H, Wang L, Wu X, Yan J, He Y, Ni B, et al. Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice. J Cell Mol Med 2010; 14: 1717-25.
30. Kurien BT, Scofield RH,. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008; 7: 567-73.
31. Scofield RH, Kurien BT, Ganick S, McClain MT, Pye Q, James JA, et al. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic Biol Med 2005; 38: 719-28.
32. Savarese E, Chae OW, Trowitzsch S, Weber G, Kastner B, Akira S, et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 2006; 107: 3229-34.
33. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-33.
34. Emlen W, Niebur J, Kadera R,. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 3685-92.
35. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002; 196: 135-40.
36. Dunoyer-Geindre S, Kruithof EK, Galve-de Rochemonteix B, Rosnoblet C, Gruenberg J, Reber G, et al. Localization of β2-glycoprotein 1 in late endosomes of human endothelial cells. Thromb Haemost 2001; 85: 903-7.
37. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ,. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006; 25: 417-28.
38. Clancy RM, Alvarez D, Komissarova E, Barrat FJ, Swartz J, Buyon JP,. Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block. J Immunol 2010; 184: 2148-55.
39. Prinz N, Clemens N, Strand D, Putz I, Lorenz M, Daiber A, et al. Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells. Blood 2011; 118: 2322-32.